A cardiac event monitor is a device that is used to record the heart’s electrical activity (ECG). It keeps track of the heartbeat and rhythm. When there is a need for long-term monitoring of symptoms that don’t happen every day, cardiac event monitors are employed. Important heart health data can be tracked, recorded, and sent to the doctor in real-time using a cardiac monitoring gadget. This reduces the need for frequent visits to the doctor’s office, allowing the care team to monitor heart health from a distance.
Boston Scientific Corporation and Abbott Laboratories – Notable Market Players in Cardiac Monitoring Devices Market
Market leaders operating in the market have undertaken various organic growth strategies in the cardiac monitoring devices market. The cardiac monitoring devices market majorly consists of players are MicroPort, Medi-Lynx Cardiac Monitoring LLC, BTL, Lepu Medical, Medtronic, Abbott, Mindray and BIOTRONIK. The companies have been implementing various strategies that have helped the growth of the company and in turn have brought about various changes in the market. The companies have utilized organic strategies such as launches, expansion, and product approvals. Moreover, the companies have utilized inorganic strategies including mergers & acquisitions, partnership, and collaboration.
Below is the list of the growth strategies done by the players operating in the cardiac monitoring devices market:
| Company | Month & Year | Category | Description |
| Jan-2022 | MicroPort | Product Approval | MicroPort CRM, a pioneering company in the field of Cardiac Rhythm Management, headquartered in France, recently received PMDA Japanese regulation agency approval for its latest range of implantable pacemakers, Alizea. The devices are equipped with Bluetooth technology for streamlined remote monitoring when paired with MicroPort CRM’s SmartView Connect™ home monitor, already approved in Japan. |
| Jan-2022 | Medi-Lynx Cardiac Monitoring, LLC | Product News | Medi-Lynx Cardiac Monitoring, LLC (dba MediLynx Arrhythmia Diagnostics) announced that its parent company, MEDICALgorithmics S.A. has received a broad patent (US Patent No. 11,183,305) for continuous (full-disclosure) ECG streaming, analysis and monitoring from a remote location. |
| Dec-2021 | BTL | Expansion | BTL Austria was established in Graz in December 2021. BTL Austria will offer leading expert service, training, and support to all our valued customers whilst introducing them to new medical and aesthetics technologies to enhance their services and businesses. |
| Jul-2021 | Medtronic | Product Approval | Medtronic plc, the global leader in medical technology, has announced U.S. Food and Drug Administration (FDA) clearance for two AccuRhythm AI algorithms for use with the LINQ II insertable cardiac monitor (ICM). AccuRhythm AI applies artificial intelligence (AI) to heart rhythm event data collected by LINQ II, improving the accuracy of information physicians receive so they can better diagnose and treat abnormal heart rhythms. |
| Jul-2021 | Abbott | Product News | Abbott has announced the U.S. launch of Jot Dx, the company’s latest insertable cardiac monitor (ICM). The Jot Dx ICM gives clinicians and hospitals control of how they manage the flow of information through a unique feature to view either all abnormal heart rhythm data or to simplify which irregular heart rhythms are recorded with a “key episodes” option. This technology allows for remote detection and improved diagnosis accuracy of cardiac arrythmia in patients. Jot Dx ICM is supported by SyncUP, a personalized service that delivers one-on-one training and education to help patients get connected and stay connected to their ICM. |
| Jun-2021 | Lepu Medical | Product Launch | Shenzhen Carewell Electronics Co., Ltd., a subsidiary of Lepu Medical, launched its new ECG tablets–Neo ECG T180 and Neo ECG S120. Supporting connection with AI-ECG Platform, Neo ECG allows the hospitals and medical centers to achieve intelligence diagnosis. This marks Lepu’s solid step towards AI-powered solutions. |
| May-2021 | Medtronic | Product Launch | Medtronic plc, the global leader in medical technology, today announced the U.S. commercial launch of the SonarMed airway monitoring system. The first and only device of its kind, the SonarMed airway monitoring system utilizes acoustic technology to check for endotracheal tube (ETT) obstruction and verify position in real-time, giving clinicians vital information required to make more informed, life-saving decisions for their smallest patients. |
| Apr-2021 | Mindray | Company News | Mindray has launched its universally connected platform, M-Connect, which unlocks the potential of individual patient monitoring with an integrated IT solution. This innovative platform helps medical providers build a well-rounded healthcare ecosystem and greatly boosts efficiency. |
| Jan-2020 | BIOTRONIK | Product Launch | BIOTRONIK’s next-generation ICM comes ready to inject, with the device pre-assembled in a one-step injection tool. To optimize patient comfort, BIOMONITOR III offers a very small size and flexible sensing antenna. The device is injected under the skin with a very small incision, allowing for a quick and easy injection procedure. |
